Big Pharma Chasing Obesity Drug Boom

Michael Shah, Senior Equity Research Analyst, Bloomberg Intelligence

18-Jan-24 07:30

Pause
Embed

The chronic weight management market is at an inflection point. Analysts have forecast that sales of weight-loss drugs could potentially hit 100 billion US dollars by 2030, buoyed by promising results in recent clinical trials. We speak to Michael Shah, Senior Equity Research Analyst at Bloomberg Intelligence for insights into this growing market.

Image credit: Shutterstock.com

Produced by: Chin Wai Lun

Presented by: Shazana Mokhtar, Wong Shou Ning, Keith Kam

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories: technology, medical advances

Tags: weight loss drugs, pharmaceutical companies medical trials, big pharma, clinical trials,

Today’s Shows

11:00 AM

Best of Enterprise

(REPEAT) We unpack the complexities of CEO succession, especially in founder-led or family-run companies that dominate Malaysia’s corporate landscape.

12:00 PM

Popcorn Culture

(REPEAT) We review season 2 of Andor and talk about the value of binge watching versus savouring episodes on a week to week basis.

1:00 PM

Cruise Control

(REPEAT) What’s cool at The Malaysia Autoshow 2025? Join us as we share some of the highlights!

2:00 PM

Matt-Splained

(REPEAT) Rich and Matt pay tribute to Gen X and reflect on simpler times.

3:00 PM

Earth Matters

(REPEAT) We explore the troubling trade behind songbird competitions and their threats to our ecosystem.

4:00 PM

Bar None

(REPEAT) It’s squat, bench and deadlift on this episode of Bar None as we speak to Kenneth Kaden Chin, a powerlifter and the Deputy President of the Malaysian Association for Powerlifting.

5:00 PM

BBC World Service

BFM presents the BBC World Service, which provides in-depth coverage of issues from around the world.

PROGRAMMES